Increased PD-1+ and TIM-3+ TILs during Cetuximab Therapy Inversely Correlate with Response in Head and Neck Cancer Patients
Crossref DOI link: https://doi.org/10.1158/2326-6066.CIR-16-0333
Published Online: 2017-05-01
Published Print: 2017-05-01
Update policy: https://doi.org/10.1158/crossmark_policy
Jie, Hyun-Bae
Srivastava, Raghvendra M.
Argiris, Athanassios
Bauman, Julie E.
Kane, Lawrence P.
Ferris, Robert L.
Funding for this research was provided by:
NIH (R01 DE019727, P50 CA097190, CA206517)
University of Pittsburgh Cancer Institute (P30CA047904)
